The report analyzes and forecasts the pharmaceutical continuous manufacturing market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of pharmaceutical continuous manufacturing, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major pharmaceutical continuous manufacturing companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of pharmaceutical continuous manufacturing upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of pharmaceutical continuous manufacturing and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global pharmaceutical continuous manufacturing market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the pharmaceutical continuous manufacturing market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of pharmaceutical continuous manufacturing market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global pharmaceutical continuous manufacturing technology market. The report also profiles key players operating in the pharmaceutical continuous manufacturing technology market which are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences, Chemtrix, Ehrfeld etc.
The global pharmaceutical continuous manufacturing technology market is segmented as follows:
Global Pharmaceutical continuous manufacturing technology Market, by Application Type
Global Pharmaceutical continuous manufacturing technology Market, by End-users
Global Pharmaceutical continuous manufacturing technology Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Pharmaceutical Continuous Manufacturing Technology Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Market Opportunity Map
4.3. Key Industry Events
4.4. Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, 2017–2026
4.5. Global Pharmaceutical Continuous Manufacturing Technology Market Outlook
4.6. Porter’s Five Forces Analysis
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increased inefficiency in the manufacturing process
5.2.2. Safer production
5.2.3. Advantages over the batch manufacturing
5.2.4. Increased FDA initiatives
5.3. Restraints
5.3.1. Regulatory challenges
5.3.2. Difficulties in adoption
5.4. Opportunities
5.4.1. Improving Pharma Infrastructure
5.5. Global API Manufacturing Technology Suppliers Market Share Analysis, by Company, 2016 (estimated)
6. Global Pharmaceutical Continuous Manufacturing Technology Market, by Application
6.1. Introduction
6.2. Key Findings
6.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
6.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
6.5. Global Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
6.6. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Application
6.7. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application
6.8. Key Trends
7. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user
7.1. Introduction
7.2. Key Findings
7.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
7.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
7.5. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user
7.6. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user
7.7. Key Trends
8. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Region
8.1. Global Market Scenario, by Country
8.2. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Region
8.3. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Region, 2017–2026
8.4. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Region
9. North America Pharmaceutical Continuous Manufacturing Technology Market Analysis
9.1. Key Findings
9.2. North America Pharmaceutical Continuous Manufacturing Technology Market Overview
9.3. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
9.4. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
9.5. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
9.6. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
9.7. North America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
9.8. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
9.9. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
9.10. North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
9.11. Key Trends
10. Europe Pharmaceutical Continuous Manufacturing Technology Market Analysis
10.1. Key Findings
10.2. Europe Pharmaceutical Continuous Manufacturing Technology Market Overview
10.3. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
10.4. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
10.5. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
10.6. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
10.7. Europe Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
10.8. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
10.9. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
10.10. Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
10.11. Key Trends
11. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Analysis
11.1. Key Findings
11.2. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Overview
11.3. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
11.4. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
11.5. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
11.6. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
11.7. Asia Pacific Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
11.8. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
11.9. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
11.10. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
11.11. Key Trends
12. Latin America Pharmaceutical Continuous Manufacturing Technology Market Analysis
12.1. Key Findings
12.2. Latin America Pharmaceutical Continuous Manufacturing Technology Market Overview
12.3. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
12.4. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
12.5. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
12.6. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
12.7. Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
12.8. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
12.9. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
12.10. Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
13. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Overview
13.3. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
13.4. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
13.5. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
13.6. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
13.7. Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
13.8. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
13.9. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
13.10. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
14. Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. Siemens AG
14.2.1.1. Company Details
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. GEA Group
14.2.2.1. Company Details
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. SK biotek Co., Ltd.
14.2.3.1. Company Details
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. CONTINUUS Pharmaceuticals
14.2.4.1. Company Details
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. Gebrüder Lödige Maschinenbau GmbH
14.2.5.1. Company Details
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Glatt GmbH
14.2.6.1. Company Details
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. KORSCH AG
14.2.7.1. Company Details
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Scott Equipment Company
14.2.8.1. Company Details
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Thermo Fisher Scientific, Inc.
14.2.9.1. Company Details
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. L.B. Bohle Maschinen + Verfahren Gmbh
14.2.10.1. Company Details
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Munson Machinery Company
14.2.11.1. Company Details
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers